Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 6 studies | 32% ± 22% | |
endothelial cell | 5 studies | 23% ± 5% | |
epithelial cell | 4 studies | 20% ± 6% | |
placental villous trophoblast | 3 studies | 55% ± 21% | |
GABAergic neuron | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6873.89 | 1445 / 1445 | 100% | 73.77 | 183 / 183 |
uterus | 100% | 9730.02 | 170 / 170 | 100% | 70.53 | 459 / 459 |
skin | 100% | 7458.16 | 1808 / 1809 | 100% | 102.06 | 472 / 472 |
thymus | 100% | 9117.03 | 653 / 653 | 100% | 71.80 | 604 / 605 |
prostate | 100% | 9672.47 | 245 / 245 | 100% | 84.98 | 501 / 502 |
brain | 100% | 9010.71 | 2638 / 2642 | 100% | 93.74 | 704 / 705 |
pancreas | 100% | 3438.23 | 327 / 328 | 100% | 49.84 | 178 / 178 |
stomach | 100% | 5581.44 | 359 / 359 | 100% | 61.09 | 285 / 286 |
ovary | 100% | 10346.18 | 180 / 180 | 100% | 80.89 | 428 / 430 |
intestine | 100% | 7279.47 | 966 / 966 | 99% | 56.63 | 523 / 527 |
breast | 100% | 6273.60 | 459 / 459 | 99% | 67.71 | 1109 / 1118 |
lung | 100% | 7799.78 | 577 / 578 | 99% | 56.93 | 1145 / 1155 |
kidney | 100% | 5201.28 | 89 / 89 | 99% | 41.53 | 890 / 901 |
bladder | 100% | 8428.05 | 21 / 21 | 99% | 57.65 | 497 / 504 |
adrenal gland | 100% | 4750.70 | 258 / 258 | 98% | 49.55 | 226 / 230 |
liver | 100% | 4413.20 | 226 / 226 | 96% | 31.73 | 389 / 406 |
adipose | 100% | 6435.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 79.22 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 53.09 | 29 / 29 |
spleen | 100% | 6092.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 72.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.07 | 1 / 1 |
blood vessel | 100% | 7217.10 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 4566.75 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4831.51 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 7246.11 | 883 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0008023 | Cellular component | transcription elongation factor complex |
GO_0001650 | Cellular component | fibrillar center |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | MLLT1 |
Protein name | Protein ENL (YEATS domain-containing protein 1) |
Synonyms | ENL LTG19 YEATS1 |
Description | FUNCTION: Chromatin reader component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA . Specifically recognizes and binds acetylated and crotonylated histones, with a preference for histones that are crotonylated . Has a slightly higher affinity for binding histone H3 crotonylated at 'Lys-27' (H3K27cr) than 'Lys-20' (H3K9cr20) . .; FUNCTION: Acts as a key chromatin reader in acute myeloid leukemia by recognizing and binding to acetylated histones via its YEATS domain, thereby regulating oncogenic gene transcription. . |
Accessions | ENST00000252674.9 Q03111 |